School personnel information


Iwasaki Masaharu

Organization 【 display / non-display

  • 2018.02.01 - , Research Institute for Microbial Diseases, Associate Professor


Academic Papers 【 display / non-display

  • A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region., Cai Y, Iwasaki M, Motooka D, Liu DX, Yu S, Cooper K, Hart R, Adams R, Burdette T, Postnikova EN, Kurtz J, St Claire M, Ye C, Kuhn JH, Martínez-Sobrido L, de la Torre JC, mBio,11(2), 2020.03, Papers

  • A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene., Cai Y, Ye C, Cheng B, Nogales A, Iwasaki M, Yu S, Cooper K, Liu DX, Hart R, Adams R, Brady T, Postnikova EN, Kurtz J, St Claire M, Kuhn JH, de la Torre JC, Martínez-Sobrido L, mBio,11(1), 2020.02, Papers

  • Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays., Caì Y, Iwasaki M, Beitzel BF, Yú S, Postnikova EN, Cubitt B, DeWald LE, Radoshitzky SR, Bollinger L, Jahrling PB, Palacios GF, de la Torre JC, Kuhn JH, Viruses,10(11), 2018.11, Papers

  • Use of recombinant ML29 platform to generate polyvalent live-attenuated vaccines against Lassa fever and other infectious diseases., Iwasaki M,第66回日本ウイルス学会学術集会, 2018.10, Conference Report / Oral Presentation

  • A Highly Conserved Leucine in Mammarenavirus Matrix Z Protein Is Required for Z Interaction with the Virus L Polymerase and Z Stability in Cells Harboring an Active Viral Ribonucleoprotein., Iwasaki M, de la Torre JC, Journal of virology,92(11) e02256-17, 2018.05, Papers

display all >>


Lecture / Exhibition 【 display / non-display

  • Tokushima University MD-PhD Course, 2019.02